HSK-36357

N/A

Report date: 2025/12/16 13:53:59
NME

Base Information

Drug NameHSK-36357
Drug Alias NameHSK36357HSK-36357
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAP2-associated protein kinase 1 inhibitors
TargetsAP2-associated protein kinase 1
Therapy Area/IndicationsNeuralgiaMuscular Dystrophies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesTibet Haisco Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesTibet Haisco Pharmaceutical Co LtdShanghai Haisi Shengnuo Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsNeuralgiaMuscular Dystrophies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A